Taken together, these findings demonstrate that PD-1 deficiency or anti–PD-1 therapy in mice with liver injury is associated with improved KC bacterial clearance, reduced tissue bacterial burden, and protection from sepsis after infection. Here, PDCD1 is linked to infection.